Literature DB >> 18802168

Non-Hodgkin's lymphoma in patients with glioma treated with temozolomide.

Bart Neyns, Susanna Cordera, Eric Joosens, Nader Pouratian, Pouratian Nader.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802168     DOI: 10.1200/JCO.2008.18.8177

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Plasmablastic lymphoma after standard-dose temozolomide for newly diagnosed glioblastoma.

Authors:  Stephen W Clark; Jennie Taylor; Daphne L Wang; Jeremy S Abramson; Tracy T Batchelor
Journal:  Neurology       Date:  2013-05-17       Impact factor: 9.910

Review 2.  Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.

Authors:  Sebastian Zahnreich; Heinz Schmidberger
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

3.  Second cancers in patients with neuroendocrine tumors.

Authors:  Hui-Jen Tsai; Chun-Chieh Wu; Chia-Rung Tsai; Sheng-Fung Lin; Li-Tzong Chen; Jeffrey S Chang
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

4.  Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor.

Authors:  D J Voce; A M Schmitt; A Uppal; M E McNerney; G M Bernal; K E Cahill; J S Wahlstrom; A Nassiri; X Yu; C D Crawley; K P White; K Onel; R R Weichselbaum; B Yamini
Journal:  Oncogene       Date:  2014-07-21       Impact factor: 9.867

5.  Non-hodgkin lymphoma after treatment with extended dosing temozolomide and radiotherapy for a glioblastoma: a case report.

Authors:  Laura Van Ginderachter; Tony Cox; Ria Drijkoningen; Ruth Achten; Eric Joosens; Annelies Maes; Koen Theunissen; Jeroen Mebis
Journal:  Case Rep Oncol       Date:  2013-01-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.